This inventor holds 1 USPTO granted patent. Top assignee: University of Warsaw. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Marcin Warmiński: Innovator in mRNA Technology
Introduction
Marcin Warmiński is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of molecular biology, particularly in the development of mRNA technologies. His innovative work focuses on enhancing the stability and efficacy of mRNA for therapeutic applications.
Latest Patents
Warmiński holds a patent for "5'-phosphorothiolate mRNA 5′-end (cap) analogs, mRNA comprising the same, method of obtaining and uses thereof." This invention relates to nucleotides and analogs of mRNA 5'-end (cap) that contain a sulfur atom at the position 5′ of 7-methylguanosine nucleoside. The disclosed compounds are recognized and bound by the DcpS enzyme, which is a cap-specific enzyme with pyrophosphatase activity. This invention has potential therapeutic applications, particularly as inhibitors of DcpS, which is identified as a target in the treatment of spinal muscular atrophy (SMA). The compounds also feature modifications in the phosphate chain that enhance their affinity for the DcpS enzyme.
Career Highlights
Warmiński is affiliated with the University of Warsaw, where he conducts research and develops innovative solutions in the field of mRNA technology. His work has garnered attention for its potential impact on therapeutic strategies for various diseases.
Collaborations
Some of his notable coworkers include Jacek Jemielity and Kaja Fac-Dąbrowska. Their collaborative efforts contribute to advancing research in the field of molecular biology and therapeutic applications.
Conclusion
Marcin Warmiński is a pioneering inventor whose work in mRNA technology holds promise for future therapeutic advancements. His contributions to the field are significant and reflect a commitment to innovation in molecular biology.